Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 7/20 | 0.65 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.65 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.65 |
| ▸ | HPGD | P15428 | 1/20 | 0.64 |
| ▸ | TP53 | P04637 | 3/20 | 0.54 |
| ▸ | HIF1A | Q16665 | 3/20 | 0.54 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.54 |
| ▸ | THRB | P10828 | 2/20 | 0.44 |
| ▸ | ATM | Q13315 | 1/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | HCAR2 | Q8TDS4 | 3/20 | 0.37 |
| ▸ | ACHE | P22303 | 1/20 | 0.35 |
| ▸ | PAOX | Q6QHF9 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15249365 | 0.94 | TSHR (0.69) | TSHRALDH1A1CYP3A4HPGDTP53 | |
| SCHEMBL28998241 | 0.92 | TSHR (0.73) | TSHRALDH1A1CYP3A4HPGDTP53 | |
| SCHEMBL12750069 | 0.92 | TSHR (0.73) | TSHRALDH1A1CYP3A4HPGDTP53 | |
| SCHEMBL13607753 | 0.92 | TSHR (0.73) | TSHRALDH1A1CYP3A4HPGDTP53 | |
| SCHEMBL15313577 | 0.92 | TSHR (0.73) | TSHRALDH1A1CYP3A4HPGDTP53 | |
| SCHEMBL28547369 | 0.88 | TSHR (0.65) | TSHRALDH1A1CYP3A4HPGDTP53 | |
| SCHEMBL8333843 | 0.87 | TSHR (0.76) | TSHRALDH1A1CYP3A4HPGDTP53 | |
| SCHEMBL3783039 | 0.87 | TSHR (0.58) | TSHRALDH1A1CYP3A4HPGDTP53 | |
| SCHEMBL8460859 | 0.86 | TSHR (0.63) | TSHRALDH1A1CYP3A4HPGDTP53 | |
| SCHEMBL22561253 | 0.86 | TSHR (0.63) | TSHRALDH1A1CYP3A4HPGDTP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230242809-A1 | PHOTOCHROMIC HYDROXYURETHANE COMPOUND | TOKUYAMA CORPORATION (JP) | 2023-08-03 | — | — | US | disclosed |
| CN-114058214-A | UV (ultraviolet) curing inkjet ink and preparation method thereof | 乐凯华光印刷科技有限公司 | 2022-02-18 | — | — | CN | disclosed |
| US-9458269-B2 | Polymerizable composition, antireflection film, polarizing plate and image display device each using the same, and water-repellent or oil-repellent film | FUJIFILM CORPORATION (JP) | 2016-10-04 | — | — | US | disclosed |
| US-20150024267-A1 | ELECTROLYTE HAVING IMPROVED HIGH-RATE CHARGE AND DISCHARGE PROPERTY, AND CAPACITOR COMPRISING SAME | UNIVERSITY OF SEOUL INDUSTRY COOPERATION FOUNDATION (KR) | 2015-01-22 | — | — | US | disclosed |
| US-8710113-B2 | Dental composition, kit of parts and use thereof | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2014-04-29 | — | — | US | disclosed |
| US-20130109777-A1 | DENTAL COMPOSITION, KIT OF PARTS AND USE THEREOF | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2013-05-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130109777-A1 | DENTAL COMPOSITION, KIT OF PARTS AND USE THEREOF | KIT, KDM5C, PHAX | TSHR 4041/4885ALDH1A1 2380/4885CYP3A4 2983/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.